ABOUT: Acutus is an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated. Acutus is committed to advancing the field of electrophysiology with a unique array of products and technologies which […]
THIS INTERVIEW HAS EXPIRED
Interview with Rick Van Kirk, CEO […]
THIS INTERVIEW HAS EXPIRED
Interview with Rob Ellin, CEO, Chairman, and Founder […]
THIS INTERVIEW HAS EXPIRED
THIS INTERVIEW HAS EXPIRED
ABOUT: Safe Harbor is among the first service providers to offer compliance, monitoring and validation services to financial institutions, providing access to traditional banking services to cannabis, hemp, CBD, and ancillary operators, making communities safer, […]
ABOUT: Inhibikase Therapeutics, Inc. (Nasdaq: IKT) is a clinical-stage pharmaceutical company developing therapeutics for Parkinson’s disease and related disorders. Inhibikase’s multi-therapeutic pipeline has a primary focus on neurodegeneration and its lead program IkT-148009, an Abelson […]
THIS INTERVIEW HAS EXPIRED
Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com